| Presurgical evaluation of epilepsy F Rosenow, H Lüders Brain 124 (9), 1683-1700, 2001 | 2122 | 2001 |
| Semiological seizure classification. H Lüders, J Acharya, C Baumgartner, S Benbadis, A Bleasel, R Burgess, ... Epilepsia 39 (9), 1006-1013, 1998 | 930 | 1998 |
| Histopathological findings in brain tissue obtained during epilepsy surgery I Blumcke, R Spreafico, G Haaker, R Coras, K Kobow, CG Bien, M Pfäfflin, ... New England Journal of Medicine 377 (17), 1648-1656, 2017 | 876 | 2017 |
| 15q13. 3 microdeletions increase risk of idiopathic generalized epilepsy I Helbig, HC Mefford, AJ Sharp, M Guipponi, M Fichera, A Franke, ... Nature genetics 41 (2), 160-162, 2009 | 692 | 2009 |
| Incidence of status epilepticus in adults in Germany: a prospective, population‐based study S Knake, F Rosenow, M Vescovi, WH Oertel, HH Mueller, A Wirbatz, ... Epilepsia 42 (6), 714-718, 2001 | 638 | 2001 |
| Leitlinien für Diagnostik und Therapie in der Neurologie HC Diener, C Weimar, P Berlit, G Deuschl, C Elger, R Gold, W Hacke, ... Thieme Verlag, 2012 | 537 | 2012 |
| Recurrent microdeletions at 15q11. 2 and 16p13. 11 predispose to idiopathic generalized epilepsies CGF de Kovel, H Trucks, I Helbig, HC Mefford, C Baker, C Leu, C Kluck, ... Brain 133 (1), 23-32, 2010 | 518 | 2010 |
| Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures GL Krauss, JM Serratosa, V Villanueva, M Endziniene, Z Hong, J French, ... Neurology 78 (18), 1408-1415, 2012 | 501 | 2012 |
| State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation W Paulus, J Classen, LG Cohen, CH Large, V Di Lazzaro, M Nitsche, ... Brain stimulation 1 (3), 151-163, 2008 | 473 | 2008 |
| De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies S Appenzeller, R Balling, N Barisic, S Baulac, H Caglayan, D Craiu, ... The American Journal of Human Genetics 95 (4), 360-370, 2014 | 468 | 2014 |
| Proposed consensus definitions for new‐onset refractory status epilepticus (NORSE), febrile infection‐related epilepsy syndrome (FIRES), and related conditions LJ Hirsch, N Gaspard, A van Baalen, R Nabbout, S Demeret, ... Epilepsia 59 (4), 739-744, 2018 | 454 | 2018 |
| Adjunctive lacosamide for partial‐onset seizures: efficacy and safety results from a randomized controlled trial P Halász, R Kälviäinen, M Mazurkiewicz‐Beldzińska, F Rosenow, P Doty, ... Epilepsia 50 (3), 443-453, 2009 | 442 | 2009 |
| Cytokines and epilepsy G Li, S Bauer, M Nowak, B Norwood, B Tackenberg, F Rosenow, S Knake, ... Seizure 20 (3), 249-256, 2011 | 348 | 2011 |
| The phenotypic spectrum of SCN8A encephalopathy J Larsen, GL Carvill, E Gardella, G Kluger, G Schmiedel, N Barisic, ... Neurology 84 (5), 480-489, 2015 | 307 | 2015 |
| De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy S Syrbe, UBS Hedrich, E Riesch, T Djémié, S Müller, RS Møller, B Maher, ... Nature genetics 47 (4), 393-399, 2015 | 303 | 2015 |
| Transcutaneous vagus nerve stimulation (tVNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02) S Bauer, H Baier, C Baumgartner, K Bohlmann, S Fauser, W Graf, ... Brain stimulation 9 (3), 356-363, 2016 | 290 | 2016 |
| Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals YCA Feng, DP Howrigan, LE Abbott, K Tashman, F Cerrato, T Singh, ... The American Journal of Human Genetics 105 (2), 267-282, 2019 | 270 | 2019 |
| Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study HJ Lamberink, WM Otte, I Blümcke, KPJ Braun, M Aichholzer, I Amorim, ... The Lancet Neurology 19 (9), 748-757, 2020 | 268 | 2020 |
| International consensus based review and recommendations for minimum reporting standards in research on transcutaneous vagus nerve stimulation (version 2020) AD Farmer, A Strzelczyk, A Finisguerra, AV Gourine, A Gharabaghi, ... Frontiers in human neuroscience 14, 568051, 2021 | 266 | 2021 |
| De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome A Suls, JA Jaehn, A Kecskés, Y Weber, S Weckhuysen, DC Craiu, ... The American Journal of Human Genetics 93 (5), 967-975, 2013 | 264 | 2013 |
Adam StrzelczykGoethe-University Frankfurtmed.uni-frankfurt.de의 이메일 확인됨